Stage 2 Meaningful Use Criteria: Your Support Guide
Now that the government has released the 2014 Edition of Meaningful Use (also called Stage 2), it will be important for EHR vendors to ensure that they can meet all the required criteria. Here's a...
View ArticleClik here to view.
Patient portals now required by Meaningful Use
Recently, Physicians Practice reported on the challenges facing both providers and EHR vendors when it comes to new Stage 2 Meaningful Use rules. One item noted in the article is that patient portals...
View ArticleMeaningful Use Now Addressing Patient Portals
I just read a posting by my colleague Matt Bennardo about how Meaningful Use is now addressing patient portals. A very informative posting. In case you missed it, I am pulling out an excerpt...
View ArticleEMR certification requires a drug database that is easy to work with
EMR vendors end up in a time crunch to select a drug database if they don't take the time of evaluating them early in the process. This is an often overlooked, but very important component especially...
View ArticleEMRs -- time to move forward. Election is over. Meaningful Use, Drug Data,
Now that the election is now over, the next six months will be interesting to watch. There had a bit of slow down and a wait and see attitude. Those EMRs that were on the fence, will likely start...
View ArticlePost-election: What is the future for Meaningful Use?
With the U.S. elections over and President Obama retaining the White House (along with Democratic majority in the Senate), it appears that Meaningful Use is here to stay. Earlier in the year, the...
View ArticleMeaningful Use, Patient Portals and other thoughts
I just re-read a posting by my colleague Matt Bennardo about how Meaningful Use is now addressing patient portals. A very informative posting. Although I posted this before, I am re-posting again...
View ArticleDrug Interactions
Healthcare professionals are faced with frequent drug interaction alerts on a daily basis. They are faced with the challenge of measuring the risk of these potential interactions to the patient prior...
View ArticleAnswering Key Drug-Drug Interactions Questions
Last month, I attended a drug-drug interaction (DDI) clinical decision support (CDS) conference funded by the Agency for Healthcare Research & Quality (AHRQ) and organized by the University of...
View Article5 Benefits to using Medi-Span for Developers
Medi-Span continues to be ranked as one of the top drug databases for EMR/EHR software vendors. So what benefits does it offer to developers?Meaningful Use support: Including drug-drug and...
View ArticleRepresentations of liquid volume -- mL is our one and only
Medi-Span® offers its drug descriptive data in a variety of formats, including unformatted flat files and data with accompanying application programming interface (API) software. Since the inception...
View ArticleUpcoming Webinar - The HL7 InfoButton Today: Best Practices for Drug...
Are you using InfoButton in your EHR or healthcare application?No...Then, you could be missing out an efficient way to access important clinical resources right within the workflow.Yes... Are you sure...
View ArticleDesign of Decision Support Interventions
Medication safety screening, as I have written about at length previously, has the potential to reduce prescribing errors and therefore to improve patient safety. I have also previously described alert...
View ArticleHelping EMR Vendors Meeting Meaningful Use with Medi-Span Clinical
Now that the government has released the 2014 Edition of Meaningful Use (also called Stage 2), it will be important for EHR vendors to ensure that they can meet all the required criteria. Here's a...
View ArticleAMIA 2013: Updates on Medication Safety Screening and CDS Standards
The AMIA 2013 conference was last month in Washington, DC. I had the honor of giving two talks on topics I often discuss on the Wolters Kluwer Health blog – medication safety screening and clinical...
View Article
